Stockhub

Aequus Pharmaceuticals Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 August 2022

  • curprev 03:3303:33, 17 August 2022 >Paris 1,454 bytes +1,454 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and preve..."
Retrieved from "https://stockhub.co/research/Aequus_Pharmaceuticals_Inc."